GSK to buy US cancer drug firm IDRx for up to $1.15bn

GSK

Massachusetts-based company is working on new treatments for gastrointestinal cancers Massachusetts-based company is working on new treatments for gastrointestinal cancers

Tag-uri: GSK

GSK to buy US cancer drug firm IDRx for up to $1.15bn https://www.theguardian.com - 13.01.2025 15:44

din zilele anterioare

GSK to buy US cancer drug firm IDRx for up to $1.15bn https://www.theguardian.com - 13.01.2025 15:44